ReviewEye (London, England)2017
Aflibercept in age-related macular degeneration: evaluating its role as a primary therapeutic option.
M Ashraf et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it